針對的肌膚問題

淡化魚尾紋

減退額頭紋

撫平眉心紋

減少腋汗分泌

撫平面部皺褶紋理 隱藏肌齡秘密

Anti-wrinkle & anti-aging 

BOTOX®保妥適®肉毒桿菌素專為撫平歲月累積的表情紋而設, 為全球銷量No.1品牌,目前已超過1億瓶銷售,並榮獲美國FDA認證超過30年,同時超過4,200份醫學文獻及研究支持。 當肌膚注入經高科技純化、肉毒桿菌A型中萃取的蛋白質的瞬間,時間在臉上仿如凝止,年輕永駐之旅從此揭開序幕。 只需十分鐘,BOTOX®保妥適®肉毒桿菌素能降低肌肉收縮張力,有效放鬆導致動態皺紋的面部肌肉,臉上各種曾被歲月刻劃過的細紋、皺紋,均被撫平、一一拭去。

效果見證

魚尾紋

抬頭紋

額前紋

眉心紋

皺眉紋

魚尾紋

選擇BOTOX®保妥適®肉毒桿菌素療程的原因

美國FDA認證超過30年,安全有效

全球銷量超過 1 億瓶,信心保證

FDA 認證撫平三大皺紋

去皺效果⻑達6個⽉

安心保證

原廠正版正貨保證

原廠認可的醫療中心

專業醫療團隊主理

受醫療集團監察

絕不硬銷,無額外隱藏收費

行內超過12年實踐經驗

原理及技術

BOTOX®保妥適®肉毒桿菌素去皺原理

動態皺紋,包括眉心紋、額頭紋及魚尾紋是由肌肉收縮形成。 神經細胞負責傳遞信號使肌肉收縮。BOTOX®保妥適®肉毒桿菌素能有效阻截神經細胞傳送信號,有助放鬆肌肉並撫平動態皺紋。

BOTOX®保妥適®肉毒桿菌素止汗原理

於皮下注射BOTOX®保妥適®肉毒桿菌素,可抑制神經末梢釋放神經傳導物乙醯膽鹼,
阻斷與汗腺的信號傳遞,進而抑制汗水分泌。
治療前,汗腺受到訊號刺激,分泌汗水。
治療後,抑制刺激,減少汗水分泌。

FAQ

一般而言,BOTOX®保妥適®肉毒桿菌素療程後的3至7天左右,蛋白便開始發揮功效,效果通常會維持3至6個月,視乎療程部位、皮膚類型及個人新陳代謝速度而有所不同。
BOTOX®保妥適®肉毒桿菌素是一種在嚴格監控下製造而成的高度純化蛋白質,其全球臨床經驗長達30年,並獲美國FDA認證25,國際級安全認受值得信賴。
BOTOX®保妥適®肉毒桿菌素只在療程部位產生作用, 針對性放鬆過於活躍的面部肌肉以達至去皺效果, 正確使用下並不會引起面部僵硬及構成傷害。
不會,專業醫生每次會就療程的部位與肌肉收縮強度而決定所需劑量,臨床研究顥示,BOTOX®保妥適®肉毒桿菌素會隨著療程次數的增加而延長效果的持續期,所以持續使用可逐漸減少療程的次數。

*療程效果因人而異,以上資料和相片由廠商提供,只供參考*

*療程前應根據實際情況,咨詢及參考專業意見*

*COLLAGEN+保留隨時更改或終止條款及細則的權利,而無須另行通知*

*如有任何爭議,COLLAGEN+保留最終決定權*

References:

Medical Insight, Inc 2018. Global Facial Injectables Market Study. December 2018. Based on worldwide neurotoxins market 2017 (in sales value).
Allergan. Unpublished Data. INT/0292/2018(1). March 2019. #: BOTOX® Prescribing Information. HK-41906. May 2013.
Allergan. Data on File. REF-74184.UNPUBLISHED DATA: BOTOX® number of vials shipped as of March 2019 INT/0292/2018(1). March 2019.

1. Trindade de Almeida A et al. Dermatol Surg 2015; 41: S19-S28.

2. Yu W et al. J Cosmet Laser Ther. 2018Oct;20(5):278-286.

3. U.S. Food and Drug Administration, Department of Health & Human Services. Botox approval letter 85-0226 & 85-0227, December 29, 1989.

4. Allergan. Unpublished Data. INT-BCT-2050129 – Worldwide BOTOX® marketing authorization status. October 2020.

5. Allergan. Unpublished Data. INT-BCT-2050035. BOTOX® vs competitors – number of peer reviewed articles vs competitors. February 2020.

6. Flaharty, P. (2014, April 8). Your facial wrinkles are dynamic or static. Retrieved February 10, 2022, from https://www.news-press.com/story/life/wellness/2014/04/08/beauty-tips-your-facial-wrinkles-are-dynamic-or-static/7432785/.

7. DasGupta BR. Structures of botulinum neurotoxin, its functional domains, and perspectives on the crystalline type A toxin. In: Jankovic J, Hallet, M., ed. Therapy with Botulinum Toxin. New York, NY: Marcel Decker, Inc; 1994: 15-39.

8. Coffield JA, Considine RV, Simpson LL. The site and mechanism of action of botulinum neurotoxin. In: Jankovic J, Hallet, M., ed. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc; 1994:3-13.

9. Schantz EJ, Johnson EA. Preparation and characterization of botulinum toxin type A for human treatment. In: Jankovic J, Hallet, M., ed. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc; 1994:41-49.

10. Simpson LL. The actions of clostridial toxins on storage and release of neurotransmitters. In: Harvey AL, ed. Natural and Synthetic Neurotoxins (Neuroscience Perspectives). San Diego, CA: Academic Press; 1993:278-317.

11. Black JD, Dolly JO. Interaction of 125I-labeled botulinum neurotoxins with nerve terminals II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. J Cell Biol. 1986;103(2):535-544.

12. Lebeda FJ, Hack DC, Bentry MK. Theoretical analyses of the functional regions of the heavy chain of botulinum neurotoxin. In: Jankovic J, Hallet M, ed. Therapy with Botulinum Toxin. New York, NY: Marcel Dekker, Inc; 1994:51-61.

13. Harvey AL. Presynaptic toxins. In: Smythies JR, Bradley RJ, ed. International Review of.

14. Neurobiology. San Diego, CA: Academic Press; 1990:201-239.

15. Tremaine AM, McCullough JL. Clin Cosmet Investig Dermatol. 2010;3:15–23.

16. Stotland MA et al. Plast Reconstr Surg 2007; 120(5):1386-9.

17. Beer KR et al. J Drugs Dermatol 2011;10:39-41.

18. De Boulle K et al. Dermatol Surg. 2018;44[11]:1437-1448.

19. Hyperhidrosis- Causes and Treatment of Enhanced Sweating. Dtsch Arztebl Int. 2009 Jan; 106(3):32-37.

20. Aesthetic Surg J. 2012 Feb;32(2):238-244.

21. J Am Acad Dermatol. 2007 Apr; 56(4):604-11.

22. He J, Wang T and Dong J. Journal of Dermatological Treatment. 2012 23: 461–464.

23. Naumann M and Lowe NJ. BMJ 2001;323:1–4.

4. Lowe NJ et al. J Am Acad Dermatol. 2007;56(4):604-611. 25. U.S. Food and Drug Administration, Department of Health & Human Services. Botox approval letter SUPPL-5303, October 2, 2017.

BOTOX®保妥適®(Botulinum Toxin Type A)藥品註冊編號: HK-41906. BOTOX®為醫生處方藥物,請向醫生或醫學美容中心
諮詢切合您獨特需要的專屬療程方案。療程效果因人而異。療程後如有任何不良反應,請即向醫生查詢。

Age is not a problem.

立即登記查詢 Book Now

BOTOX®
肉毒桿菌素療程
【全新客戶買1送1優惠】BOTOX®保妥適®肉毒桿菌素去皺療程 $1280 / 2個部位(魚尾紋/眉心紋/額頭紋)

Collagen+立即登記查詢

登記成功

稍後將會有職員會與你聯絡